Edenbrook Capital’s Cognyte Software CGNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,250,000
Closed -$10.1M 19
2026
Q1
$10.1M Buy
1,250,000
+645,000
+107% +$5.32M 3.15% 9
2025
Q4
$5.69M Buy
605,000
+155,000
+34% +$1.34M 1.06% 13
2025
Q3
$3.78M Buy
450,000
+250,000
+125% +$2.21M 0.65% 14
2025
Q2
$1.85M Buy
+200,000
New +$1.97M 0.4% 19
2023
Q4
Sell
-300,000
Closed -$1.44M 16
2023
Q3
$1.44M Buy
+300,000
New +$1.52M 0.32% 13

Other funds holding CGNT

Edenbrook Capital's CGNT Position: Q2 2026 in Review

Edenbrook Capital increased its Cognyte Software (CGNT) stake by 3.7% in Q2 2026, buying an estimated $2.44M and bringing the position to 7,255,224 shares worth $63.7M. The position accounts for 12.84% of the portfolio, ranked #3.

Edenbrook Capital first reported a position in CGNT in Q4 2021 and has held it in 19 quarters since. The position peaked at $65.3M in Q4 2025. 134 funds tracked by Wall St. Rank hold CGNT as of Q2 2026.

  • Edenbrook Capital held 7,255,224 shares of Cognyte Software worth $63.7M as of Q2 2026.
  • Edenbrook Capital bought 257,628 Cognyte Software shares in Q2 2026, an estimated $2.44M.
  • Cognyte Software made up 12.84% of Edenbrook Capital's portfolio in Q2 2026, its #3 holding.
  • Edenbrook Capital first reported a position in Cognyte Software in Q4 2021 and has held it in 19 quarters since.
  • Edenbrook Capital's Cognyte Software position peaked at $65.3M in Q4 2025.
  • 134 funds tracked by Wall St. Rank held Cognyte Software as of Q2 2026.

Based on Edenbrook Capital's 13F filing for Q2 2026, filed 13 Aug 2026.